• ONALESPIB chembl:CHEMBL1214827 Antineoplastic

    Alternate Names:

    ONALESPIB
    ATI-13387X
    chemidplus:912999-49-6
    chembl:CHEMBL1214827
    drugbank:06306
    pubchem.compound:11955716

    Drug Info:

    Pharmaceutical Developer Astex Pharmaceuticals
    Source Reported Drug Name(s) AT13387
    Drug Class HSP90 Inhibitor
    (0 More Sources)

    Publications:

  • Interaction Score: 10.63

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Drug family HSP90 inhibitor
    Alteration BCL6:over

    PMIDs:
    None found


    Sources:
    CGI

  • Interaction Score: 0.37

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy Crizotinib + Onalespib
    Indication/Tumor Type non-small cell lung carcinoma
    Response Type no benefit

    PMIDs:
    None found


    Sources:
    JAX-CKB

  • Interaction Score: 0.16

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Reported Cancer Type Lung

    PMIDs:
    None found


    Sources:
    CancerCommons

    • Version: 25-July-2013

    Alternate Names:
    11955716 PubChem Drug ID
    AT13387 Drug Development Name
    AT13387 Drug Trade Name

    Drug Info:
    Drug Class HSP90 Inhibitor
    Source Reported Drug Name(s) AT13387
    Pharmaceutical Developer Astex Pharmaceuticals

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:

    Drug Info:

    Publications: